tirzepatide available in india Mounjaro (Tirzepatide) clocks ₹50 Cr just 3 months in India! As reported by The Times of India, the rapid uptake of anti-obesity drugs like Mounjaro and Wegovy (Semaglutide) signals growing awareness India gets first weight-loss drug

they are medical tools designed for gradual, sustained, and significant weight loss over a longer period

The attorneys at Salvi, Schostok & Pritchard P.C

While semaglutide is considered safe for most people in managing blood sugar and weight loss, its use with IVF is not fully studied, and many fertility specialists recommend stopping it before starting an IVF cycle

Who Should Evaluate GLP-1 Use in Hashimoto's and What to Discuss Patients with Hashimoto's who are candidates for GLP-1 therapy must have separate clinical indication (obesity, type 2 diabetes, cardiovascular risk) and stable thyroid disease controlled on levothyroxine